Evan Werlin

435 total citations
14 papers, 324 citations indexed

About

Evan Werlin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Evan Werlin has authored 14 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Evan Werlin's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers) and Fatty Acid Research and Health (3 papers). Evan Werlin is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers) and Fatty Acid Research and Health (3 papers). Evan Werlin collaborates with scholars based in United States and Türkiye. Evan Werlin's co-authors include Sarah E. Greer, Joseph V. Sakran, Maureen McCunn, Bian Wu, Michael S. Conte, Tejal A. Desai, Carrie A. Sims, Melinda S. Schaller, Lance B. Becker and Mian Chen and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Evan Werlin

14 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evan Werlin United States	9	93	78	71	60	52	14	324
Fang‐Qiang Zhou United States	14	84 0.9×	41 0.5×	48 0.7×	30 0.5×	53 1.0×	33	396
Daniel L. Traber United States	10	78 0.8×	55 0.7×	51 0.7×	64 1.1×	74 1.4×	14	361
Timo Rinne Finland	12	69 0.7×	46 0.6×	89 1.3×	12 0.2×	40 0.8×	27	388
R. Hernandez United States	8	60 0.6×	36 0.5×	18 0.3×	15 0.3×	35 0.7×	31	270
Paola Arnold Germany	10	101 1.1×	69 0.9×	32 0.5×	19 0.3×	131 2.5×	21	398
F. Iscra Italy	8	36 0.4×	83 1.1×	23 0.3×	80 1.3×	59 1.1×	14	387
Yasutaka Koga Japan	10	38 0.4×	56 0.7×	55 0.8×	19 0.3×	79 1.5×	21	276
G. Heberer Germany	2	99 1.1×	48 0.6×	111 1.6×	27 0.5×	91 1.8×	2	421
N. Sennoun France	6	110 1.2×	29 0.4×	68 1.0×	10 0.2×	48 0.9×	8	353
Jeanne D. Mrozek United States	8	74 0.8×	55 0.7×	46 0.6×	21 0.3×	264 5.1×	14	399

Countries citing papers authored by Evan Werlin

Since Specialization

Citations

This map shows the geographic impact of Evan Werlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Werlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Werlin more than expected).

Fields of papers citing papers by Evan Werlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Werlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Werlin. The network helps show where Evan Werlin may publish in the future.

Co-authorship network of co-authors of Evan Werlin

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Werlin. A scholar is included among the top collaborators of Evan Werlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Werlin. Evan Werlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Levy, Elizabeth S., Evan Werlin, Mian Chen, et al.. (2023). Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries. SHILAP Revista de lepidopterología. 4. 100126–100126. 6 indexed citations

Werlin, Evan, et al.. (2022). 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury. PLoS ONE. 17(2). e0264217–e0264217. 9 indexed citations

Gomez-Sanchez, Clara, Evan Werlin, Rym El Khoury, et al.. (2022). Open revascularization approach is associated with healing and ambulation after transmetatarsal amputation in patients with chronic limb threatening ischemia. Journal of Vascular Surgery. 77(4). 1147–1154.e3. 2 indexed citations

Werlin, Evan, Hillary J. Braun, Joy Walker, et al.. (2021). Utility of a Simplified Iliac Artery Calcium Scoring System to Guide Perioperative Management for Renal Transplantation. Frontiers in Medicine. 8. 606835–606835. 7 indexed citations

Werlin, Evan, Alexander Kim, Mian Chen, et al.. (2020). A Synthetic Resolvin Analogue (Benzo-Rvd1) Attenuates Vascular Smooth Muscle Cell Migration and Neointimal Hyperplasia. SHILAP Revista de lepidopterología. 1. 247–248. 1 indexed citations

Werlin, Evan, et al.. (2019). Multibranched endovascular aortic aneurysm repair in patients with and without chronic aortic dissections. Journal of Vascular Surgery. 70(5). 1419–1426. 13 indexed citations

Mottola, Giorgio, Evan Werlin, Bian Wu, et al.. (2019). Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model. Prostaglandins & Other Lipid Mediators. 146. 106401–106401. 10 indexed citations

Conte, Michael S., Tejal A. Desai, Bian Wu, Melinda S. Schaller, & Evan Werlin. (2018). Pro-resolving lipid mediators in vascular disease. Journal of Clinical Investigation. 128(9). 3727–3735. 58 indexed citations

Wu, Bian, Evan Werlin, Mian Chen, et al.. (2018). Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model. Journal of Vascular Surgery. 68(6). 188S–200S.e4. 36 indexed citations

10.

Sims, Carrie A., et al.. (2017). Supplemental arginine vasopressin during the resuscitation of severe hemorrhagic shock preserves renal mitochondrial function. PLoS ONE. 12(10). e0186339–e0186339. 18 indexed citations

11.

Karamercan, Mehmet Akif, et al.. (2013). Can Peripheral Blood Mononuclear Cells Be Used as a Proxy for Mitochondrial Dysfunction in Vital Organs During Hemorrhagic Shock and Resuscitation?. Shock. 40(6). 476–484. 36 indexed citations

12.

Werlin, Evan, et al.. (2013). Hemorrhagic shock and resuscitation are associated with peripheral blood mononuclear cell mitochondrial dysfunction and immunosuppression. The Journal of Trauma: Injury, Infection, and Critical Care. 75(1). 24–31. 39 indexed citations

13.

Karamercan, Mehmet Akif, Scott L. Weiss, Yuxia Guan, et al.. (2013). Can Peripheral Blood Mononuclear Cells be Used as a Proxy for Mitochondrial Dysfunction in Vital Organs During Hemorrhagic Shock and Resuscitation?. Shock. 1–1. 3 indexed citations

14.

Sakran, Joseph V., Sarah E. Greer, Evan Werlin, & Maureen McCunn. (2012). Care of the injured worldwide: trauma still the neglected disease of modern society. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 20(1). 64–64. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact